Should I get a second opinion for my Glioblastoma diagnosis

GlioblastomaMay 19, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Getting a Second Opinion for Glioblastoma: A Smart Decision

Yes, seeking a second opinion is absolutely reasonable and recommended for glioblastoma. This is one of the most serious cancer diagnoses, and getting confirmation of your diagnosis and treatment plan from another qualified neuro-oncologist is a standard and encouraged practice in cancer care.

Why a Second Opinion Makes Sense for Glioblastoma

Glioblastoma is complex. According to the medical literature on glioblastoma management, treatment decisions depend on several factors:

  • Your specific tumor characteristics (like MGMT methylation status, which affects treatment response)
  • Your overall health and functional status
  • The extent of tumor removal achieved during surgery
  • Your preferences regarding treatment intensity

A second opinion helps ensure:

  • Your diagnosis is confirmed by another pathologist/neuro-oncologist
  • All relevant tumor testing has been done
  • Your treatment plan aligns with current best practices
  • You understand all available options

What to Bring to Your Second Opinion

When you see another oncologist, bring:

  • Pathology report (the detailed analysis of your tumor tissue)
  • Imaging scans (MRI images on CD, not just the reports)
  • Surgical notes if you've had surgery
  • Any molecular testing results (MGMT status, IDH mutation status, etc.)
  • Your current treatment plan from your first doctor

Treatment Options Worth Discussing

The medical literature describes several approaches for newly diagnosed glioblastoma, and your second opinion doctor should discuss:

  • Standard of care: Surgery followed by radiation therapy with concurrent chemotherapy (temozolomide)
  • Emerging immunotherapy approaches: Including personalized T-cell therapies being studied in clinical trials
  • Clinical trial eligibility: Whether you might qualify for newer treatment studies
  • Combination approaches: How different therapies might work together

According to recent glioblastoma research, treating patients with a healthy immune system and minimal residual disease (small amount of remaining tumor) tends to produce better outcomes, so timing and your overall health status matter.

Questions to Ask Your Second Opinion Doctor

  1. Do you confirm my diagnosis and pathology findings?
  2. What is my tumor's MGMT methylation status, and what does that mean for my treatment?
  3. What is your recommended treatment plan, and how does it differ from what I've been told?
  4. Am I eligible for any clinical trials, including immunotherapy studies?
  5. What is your experience treating glioblastoma patients? (You want someone who specializes in brain tumors)
  6. How would you approach combining treatments for the best outcome?

Finding a Second Opinion

Look for:

  • Neuro-oncologists (cancer doctors specializing in brain tumors) rather than general oncologists
  • Academic medical centers or comprehensive cancer centers with active glioblastoma research programs
  • Doctors affiliated with institutions conducting glioblastoma clinical trials

Many major cancer centers offer second opinion services and can review your case even if you live far away.

The Bottom Line

Getting a second opinion is not questioning your first doctor—it's being an informed, engaged patient. Most oncologists expect and respect this request. In fact, many will provide your records readily because they understand that confirming the diagnosis and treatment plan is in your best interest.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: